XUCS:XETRA:XETRA-Xtrackers MSCI USA Consumer Staples UCITS (EUR)

ETF | Others |

Last Closing

USD 42.87

Change

-0.24 (-0.55)%

Market Cap

USD 0.09B

Volume

84.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.69 (-1.33%)

USD 425.64B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.23 (-1.37%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.36 (-1.34%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.37 (-1.31%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.27 (-1.06%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.67 (-1.45%)

USD 103.65B
8R80:XETRA Amundi Index Solutions - Amund..

-1.26 (-0.88%)

USD 103.65B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.68 (-1.33%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.39 (-0.39%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-1.32 (-0.23%)

USD 80.38B

ETFs Containing XUCS:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.10% 71% C- 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.10% 72% C 72% C
Trailing 12 Months  
Capital Gain 18.82% 47% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.82% 47% F 52% F
Trailing 5 Years  
Capital Gain 40.35% 61% D- 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 40.35% 61% D- 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 7.48% 59% D- 58% F
Dividend Return 7.61% 59% D- 57% F
Total Return 0.13% 10% F 7% C-
Risk Return Profile  
Volatility (Standard Deviation) 10.44% 59% D- 67% D+
Risk Adjusted Return 72.94% 71% C- 74% C
Market Capitalization 0.09B 29% F 26% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.